Transplanted human placenta-derived stem cells show therapeutic potential in stroke models

Stem cells derived from human placenta proliferated and differentiated when transplanted into test tube and animal models of stroke. The cells interacted with melatonin receptor MT1, offering a potentially therapeutic response, but the same cells did not perform similarly when interacting with melatonin receptor MT2. The researchers suggest that MT1 "solicited" a growth factor and provided a 'cross talk' between MT1 and the stem cells.

Read the whole article on Science Daily

More from Science Daily